Paper41332151
Characterizing Apixaban Pharmacokinetics Through Physiologically-Based Pharmacokinetic Modeling: Critical Role of Biliary Secretion and Enterohepatic Circulation in Humans.
Tsuchitani T and 3 others. CPT Pharmacometrics Syst Pharmacol, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Characterizing Apixaban Pharmacokinetics Through Physiologically-Based Pharmacokinetic Modeling: Critical Role of Biliary Secretion and Enterohepatic Circulation in Humans. Papers, record 41332151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41332151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characterizing Apixaban Pharmacokinetics Through Physiologically-Based Pharmacokinetic Modeling: Critical Role of Biliary Secretion and Enterohepatic Circulation in Humans.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pyridones | Major topic |
| Pyrazoles | Major topic |
| Models, Biological | Major topic |
| Factor Xa Inhibitors | Major topic |
| Enterohepatic Circulation | Major topic |
| Bile | Major topic |
| Humans | |
| Male | |
| Adult | |
| Administration, Oral | |
| Female | |
| Healthy Volunteers | |
| Young Adult | |
| Hepatobiliary Elimination |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Japan Science Society | PubMed |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37991392 | Pharmacokinetics and pharmacodynamics of direct oral anticoagulants. | Expert Opin Drug Metab Toxicol | 2023 | https://conductscience.org/library/papers/37991392 | PubMed |
| 2 | 37101392 | Physiologically-based pharmacokinetic pharmacodynamic parent-metabolite model of edoxaban to predict drug-drug-disease interactions: M4 contribution. | CPT Pharmacometrics Syst Pharmacol | 2023 | https://conductscience.org/library/papers/37101392 | PubMed |
| 3 | 22759198 | Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects. | Br J Clin Pharmacol | 2013 | https://conductscience.org/library/papers/22759198 | PubMed |
| 4 | 33558262 | Revisiting Nonlinear Bosentan Pharmacokinetics by Physiologically Based Pharmacokinetic Modeling: Target Binding, Albeit Not a Major Contributor to Nonlinearity, Can Offer Prediction of Target Occupancy. | Drug Metab Dispos | 2021 | https://conductscience.org/library/papers/33558262 | PubMed |
| 5 | 28895074 | In Vitro Comparison of the Role of P-Glycoprotein and Breast Cancer Resistance Protein on Direct Oral Anticoagulants Disposition. | Eur J Drug Metab Pharmacokinet | 2018 | https://conductscience.org/library/papers/28895074 | PubMed |
| 6 | 33030266 | Physiologically-Based Pharmacokinetic Modeling for the Prediction of a Drug-Drug Interaction of Combined Effects on P-glycoprotein and Cytochrome P450 3A. | CPT Pharmacometrics Syst Pharmacol | 2020 | https://conductscience.org/library/papers/33030266 | PubMed |
| 7 | 34273071 | Perpetrator Characteristics of Azole Antifungal Drugs on Three Oral Factor Xa Inhibitors Administered as a Microdosed Cocktail. | Clin Pharmacokinet | 2022 | https://conductscience.org/library/papers/34273071 | PubMed |
| 8 | 39046333 | Clinical Implications of Co-administering Apixaban with Key Interacting Medications. | Clin Pharmacol Drug Dev | 2024 | https://conductscience.org/library/papers/39046333 | PubMed |
| 9 | 34095797 | Hepatic bile acid transport increases in the postprandial state: A functional 11C-CSar PET/CT study in healthy humans. | JHEP Rep | 2021 | https://conductscience.org/library/papers/34095797 | PubMed |
| 10 | 38745377 | Elucidating nonlinear pharmacokinetics of telmisartan: Integration of target-mediated drug disposition and OATP1B3-mediated hepatic uptake in a physiologically based model. | CPT Pharmacometrics Syst Pharmacol | 2024 | https://conductscience.org/library/papers/38745377 | PubMed |
| 11 | 37608051 | Induction of open-form bile canaliculus formation by hepatocytes for evaluation of biliary drug excretion. | Commun Biol | 2023 | https://conductscience.org/library/papers/37608051 | PubMed |
| 12 | 28456723 | Hepatobiliary Clearance Prediction: Species Scaling From Monkey, Dog, and Rat, and In Vitro-In Vivo Extrapolation of Sandwich-Cultured Human Hepatocytes Using 17 Drugs. | J Pharm Sci | 2017 | https://conductscience.org/library/papers/28456723 | PubMed |
| 13 | 18832478 | Apixaban metabolism and pharmacokinetics after oral administration to humans. | Drug Metab Dispos | 2009 | https://conductscience.org/library/papers/18832478 | PubMed |
| 14 | 29453492 | Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban. | Eur J Clin Pharmacol | 2018 | https://conductscience.org/library/papers/29453492 | PubMed |
| 15 | 16782767 | Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport. | Drug Metab Dispos | 2006 | https://conductscience.org/library/papers/16782767 | PubMed |
| 16 | 31219028 | The Use of Activated Charcoal to Treat Intoxications. | Dtsch Arztebl Int | 2019 | https://conductscience.org/library/papers/31219028 | PubMed |
| 17 | 17125407 | Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. | Expert Opin Drug Metab Toxicol | 2006 | https://conductscience.org/library/papers/17125407 | PubMed |
| 18 | 24277644 | Effect of activated charcoal on apixaban pharmacokinetics in healthy subjects. | Am J Cardiovasc Drugs | 2014 | https://conductscience.org/library/papers/24277644 | PubMed |
| 19 | 31506301 | Systematic Development and Verification of a Physiologically Based Pharmacokinetic Model of Rivaroxaban. | Drug Metab Dispos | 2019 | https://conductscience.org/library/papers/31506301 | PubMed |
| 20 | 37853850 | Cluster Gauss-Newton method for a quick approximation of profile likelihood: With application to physiologically-based pharmacokinetic models. | CPT Pharmacometrics Syst Pharmacol | 2024 | https://conductscience.org/library/papers/37853850 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41332151 | Characterizing Apixaban Pharmacokinetics Through Physiologically-Based Pharmacokinetic Modeling: Critical Role of Biliary Secretion and Enterohepatic Circulation in Humans. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/41332151 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| F10 | 2159 | PubTator's text mining | https://conductscience.org/library/genes/2159 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41332151
GET https://conductscience.org/api/papers/v1/41332151/references?page=2